If you were unable to attend the webinar or would like to view the webinar again, a recorded version is now available for your convenience. View Recorded Webinar

Learn about the creation of Myriad RBM’s fully validated, quantitative ApoptosisMAP and its application in cancer therapy research. The webinar highlights the main features of the service, including the ability to measure key heterodimers in the apoptosis pathway, and describes its utility for identifying responders to apoptosis inducers or other chemotherapeutic regimes.